Evaluation of a new serological technique for detecting rabies virus antibodies following vaccination.

Ma X, Niezgoda M, Blanton JD, Recuenco S, Rupprecht CE.
Journal   Vaccine.
Species  
Analytes Measured  
Matrix Tested   Human cerebrospinal fluid (CSF) and serum, dog serum, raccoon serum
Year   2012
Volume   30
Page Numbers   5358-5362
Application   Immunogenicity
Abstract
Two major techniques are currently used to estimate rabies virus antibody values: neutralization assays, such as the rapid fluorescent focus inhibition test (RFFIT), and enzyme-linked immunosorbent assays (ELISAs). The RFFIT is considered the gold standard assay and has been used to assess the titer of rabies virus neutralizing antibodies for more than three decades. In the late 1970s, ELISA began to be used to estimate the level of rabies virus antibody and has recently been used by some laboratories as an alternate screening test for animal sera. Although the ELISA appears simpler, safer and more efficient, the assay is less sensitive in detecting low values of rabies virus neutralizing antibodies than neutralization tests. This study was designed to evaluate a new ELISA-based method for detecting rabies virus binding antibody. This new technique uses electro-chemi-luminescence labels and carbon electrode plates to detect binding events. In this comparative study, the RFFIT and the new ELISA-based technique were used to evaluate the level of rabies virus antibodies in human and animal serum samples. By using a conservative approximation of 0.15IU/ml as a cutoff point, the new ELISA-based technique demonstrated a sensitivity of 100% and a specificity of 95% for human samples and for experimental animal samples. The sensitivity and specificity for field animal samples was 96% and 95%, respectively. The preliminary results from this study appear promising and demonstrate a higher sensitivity than traditional ELISA methods.

View Publications
Browse Our Products

By Analytes
By Applications
Search
Meso Scale Japan 株式会社